Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cro...
Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger GmbH
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger GmbH
Subjects
More information
Scope and Contents
Contents
Objective: Non-alcoholic fatty liver disease (NAFLD) is an established risk factor for diabetes, cardiovascular disease, antiviral treatment resistance, and progression of chronic hepatitis C virus (HCV) infection to fibrosis. Apolipoprotein-B 100 (ApoB-100) is a dyslipidemia marker and steatosis predictor. We assess the correlation between ApoB-10...
Alternative Titles
Full title
Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0b4030dde9a24b01870b293e0faf3efe
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b4030dde9a24b01870b293e0faf3efe
Other Identifiers
ISSN
1662-4025
E-ISSN
1662-4033
DOI
10.1159/000443692
